Leiden, the Netherlands, October 30, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the Jefferies Global Healthcare Conference in London, UK, on November 17-20, 2025. Fabrice Chouraqui, Chief Executive Officer, will participate in a Fireside Chat Q&A session on Wednesday, November 19 at 10:00 GMT/11:00 CET. A live webcast and replay of the presentation can be found in the “Upcoming Events” and “News” sections of Pharming ...

Core Insights - Pharming Group N.V. is implementing an organizational restructuring to accelerate growth and optimize capital allocation by reducing general and administrative expenses [1][2] Restructuring Details - The restructuring involves a redesign of the organizational structure and a 20% net reduction in non-commercial and non-medical headcount, primarily at the Netherlands headquarters [2] - The company aims to reduce total G&A expenses by 15%, equating to approximately US$10 million annually, with one-time restructuring costs expected to be around $7 million in Q4 2025 [2] Consultation Process - Pharming has engaged with its Dutch Works Council over the past several months to discuss the organizational changes in compliance with Dutch labor law [3] Company Overview - Pharming Group N.V. is a global biopharmaceutical company focused on developing and commercializing innovative medicines for patients with rare and life-threatening diseases [4]

Core Points - Pharming Group N.V. will participate in the H.C. Wainwright 27th Annual Global Investment Conference in New York from September 8-10, 2025 [1] - CEO Fabrice Chouraqui is scheduled to present on September 8 at 1:30pm EDT/19:30 CEST [1] - A live webcast and replay of the presentation will be available on Pharming's website [1] Company Overview - Pharming Group N.V. is a global biopharmaceutical company focused on developing innovative medicines for patients with rare and life-threatening diseases [3] - The company is headquartered in Leiden, the Netherlands, and operates in over 30 markets across North America, Europe, the Middle East, Africa, and Asia-Pacific [3]